September 15, 2012 (Vol. 32, No. 16)

Satendra S. Chauhan, Ph.D., is now CSO at Peptides International. Previously, Dr. Chauhan was director of organic research chemistry at Bachem Bioscience.

Satendra S. Chauhan, Ph.D.

NanoString Technologies named Dale R. Levitzke as vp of global sales for life sciences…Tokai Pharmaceuticals hired Adrian M. Senderowicz, M.D., as CMO and vp, medical development…Accelr8 Technology named Steve Reichling as CFO…Varian Medical Systems appointed Erich R. Reinhardt to its board of directors…AnaptysBio added Andrew J. McKnight, Ph.D., as senior director, target biology…Lpath appointed Daniel L. Kisner, M.D., to its board of directors.

Varian Medical Systems elected Dow R. Wilson as president and CEO. Previously, Wilson was COO at Varian. Prior to that, he was president of oncology systems there. Wilson came to Varian from GE Healthcare where he held management positions.

Dow R. Wilson

Abbie Celniker, Ph.D., joined ImaginAb as chairman of its board of directors…Randall E. Woods is now CEO at Sophiris Bio…Medgenics hired Marvin Garovoy, M.D., as CMO…Elcelyx Therapeutics appointed Ginger Graham to its to board of directors…Santosh J. Vetticaden, M.D., Ph.D., joined Adventrx Pharmaceuticals as CMO and svp…Response Biomedical appointed Bill Adams as CFO and corporate secretary…Robert W. Gergen joined RPS as vp of sales…Altura Medical added G. Ray Martin as president and CEO. Christine Larson is now vp and CFO at Dynavax Technologies.

Invetech appointed Colin White, Ph.D., as president. He formerly worked at Leica BioSystems. Prior to that, he was at Invetech as senior consultant and progressed to director of product innovation.

Colin White, Ph.D.

Threshold Pharmaceuticals hired Laura G. Hansen, Ph.D., as senior director, corporate communications…Immunovative appointed Seth M. Shaw as CEO and chairman of its board of directors and Laurence Terrisse-Rulleau, Ph.D., to its business advisory board.

Mark Wiggins joined Elcelyx Therapeutics as svp of business development. Most recently, he was CBO at Mpex Pharmaceuticals. Wiggins previously served as evp of business development at Biogen Idec. He also held senior positions at Hybridon, Schering-Plough, Johnson & Johnson, and Pfizer.

Mark Wiggins

Alliqua named Harold Schoenhaus to its scientific advisory board…Joseph Horrigan, M.D., joined Neuren Pharmaceuticals as vp of clinical development and medical affairs…Cerecor appointed Magnus Persson, M.D., Ph.D., to its board of directors…ChanTest hired Chris Mathes as CCO.

Leslie Recio, Ph.D., is the new director of genomics at ILS. Dr. Recio also serves as director of the genetic and molecular toxicology division at ILS. He has over 25 years of research experience in the areas of mutagenesis, toxicogenomics, and regulatory-based genotoxicity assessment.

Leslie Recio, Ph.D

Ren Elder is now head of pharmacy at Aetna…Cresset BioMolecular Discovery hired David Bardsley, Ph.D., as sales director…Global Green appointed Konky Sotomayor as chief scientist…Genomic Health hired Sam Levy as CSO…Appature appointed Jigish Avalani evp, global marketing and alliances…Nancy Jean Barnabei is now vp of finance and treasurer at GenSpera.

Agendia named Stefan Gluck, M.D., as chairman of its medical advisory board. Previously, Dr. Gluck was clinical director of the Braman Family Breast Cancer Institute. Prior to that, he was director of Southern Alberta Breast Cancer Program at the Tom Baker Cancer Center.

Stefan Gluck, M.D.

Send your People Announcements to [email protected].

Previous articleBayer HealthCare to Buy Teva Animal Health Business
Next articleFeatured Video: Mastering the DNA Transfection Workflow